Decomposing door-to-needle time: insights into workflow delays and quality improvement in acute stroke care
BackgroundTimely administration of intravenous recombinant tissue plasminogen activator (rtPA) significantly improves outcomes in acute ischemic stroke (AIS). However, substantial variability in door-to-needle (DTN) time persists in real-world settings. This study aimed to deconstruct DTN time into...
Saved in:
| Main Authors: | Lianyan Wei, Hongfei Li, Zhuangzhuang Jiang, Dongjuan Xu, Xiaolan Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Neurology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1651785/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE
by: T. V. Demin, et al.
Published: (2010-03-01) -
Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: a stepped-wedge trial
by: Noreen Kamal, et al.
Published: (2025-08-01) -
Impact of Onset-to-Needle Time on the Risk of Early Neurological Deterioration in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis
by: Hu B, et al.
Published: (2025-06-01) -
A nomogram for predicting early thrombolytic efficacy in stroke patients
by: Chen Lou, et al.
Published: (2025-08-01) -
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01)